| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3640 | 2015 |
| Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2603 | 2014 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2598 | 2015 |
| Proposed morphologic classification of prostate cancer with neuroendocrine differentiation JI Epstein, MB Amin, H Beltran, TL Lotan, JM Mosquera, VE Reuter, ... The American journal of surgical pathology 38 (6), 756-767, 2014 | 541 | 2014 |
| Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination BD Robinson, GL Sica, YF Liu, TE Rohan, FB Gertler, JS Condeelis, ... Clinical cancer research 15 (7), 2433-2441, 2009 | 403 | 2009 |
| Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015 | 306 | 2015 |
| Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy F Brimo, B Robinson, C Guo, M Zhou, M Latour, JI Epstein The American journal of surgical pathology 34 (5), 715-722, 2010 | 280 | 2010 |
| Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatmentrelated neuroendocrine prostate cancer JM Mosquera, H Beltran, K Park, TY MacDonald, BD Robinson, ... Neoplasia 15 (1), 1-IN4, 2013 | 267 | 2013 |
| Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee M Ittmann, J Huang, E Radaelli, P Martin, S Signoretti, R Sullivan, ... Cancer research 73 (9), 2718-2736, 2013 | 259 | 2013 |
| Role of androgen receptor and associated lysinedemethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer EC Kauffman, BD Robinson, MJ Downes, LG Powell, MM Lee, DS Scherr, ... Molecular carcinogenesis 50 (12), 931-944, 2011 | 250 | 2011 |
| Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings BD Robinson, JI Epstein The Journal of urology 184 (4), 1328-1333, 2010 | 245 | 2010 |
| Frequent truncating mutations of STAG2 in bladder cancer DA Solomon, JS Kim, J Bondaruk, SF Shariat, ZF Wang, AG Elkahloun, ... Nature genetics 45 (12), 1428-1430, 2013 | 235 | 2013 |
| Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer TE Rohan, X Xue, HM Lin, TM D’Alfonso, PS Ginter, MH Oktay, ... Journal of the National Cancer Institute 106 (8), dju136, 2014 | 210 | 2014 |
| Anatomical grades of nerve sparing: a riskstratified approach to neuralhammock sparing during robotassisted radical prostatectomy (RARP) AK Tewari, A Srivastava, MW Huang, BD Robinson, MM Shevchuk, ... BJU international 108 (6b), 984-992, 2011 | 207 | 2011 |
| SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K/mTOR and AR signaling M Blattner, D Liu, BD Robinson, D Huang, A Poliakov, D Gao, S Nataraj, ... Cancer cell 31 (3), 436-451, 2017 | 204 | 2017 |
| Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy E Xylinas, M Rink, BD Robinson, Y Lotan, M Babjuk, A Brisuda, DA Green, ... European Journal of Cancer 49 (8), 1889-1897, 2013 | 192 | 2013 |
| The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ... Archives of pathology & laboratory medicine 145 (4), 461-493, 2021 | 181 | 2021 |
| SPOP mutations in prostate cancer across demographically diverse patient cohorts M Blattner, DJ Lee, C O'Reilly, K Park, TY MacDonald, F Khani, KR Turner, ... Neoplasia 16 (1), 14-W10, 2014 | 173 | 2014 |
| Evidence for molecular differences in prostate cancer between African American and Caucasian men F Khani, JM Mosquera, K Park, M Blattner, C O'Reilly, TY MacDonald, ... Clinical Cancer Research 20 (18), 4925-4934, 2014 | 171 | 2014 |
| Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling BD Robinson, PJ Vlachostergios, B Bhinder, W Liu, K Li, TJ Moss, ... Nature communications 10 (1), 2977, 2019 | 169 | 2019 |
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and General在 meduniwien.ac.at 的电子邮件经过验证
